Substrate In Vitro Evidence:
1. Diazoxide - Ashcroft FM et al, Trends in Pharmacological Sciences, 2000: 439-445
Substrate In Vivo Evidence:
1. Gene variant associated with high insulin concentrations in non-diabetic Mexican Americans - Goksel DL et al, Human Genetics, 1998: 280-85
2. sulfonylureas - tolbutamide, glibenclamide, meglitinide (binds SUR1, but inhibits K(ATP) Channel)- Oocytes - Gribble et al, Diabetes, 1998: 1412-1418
Tissue Distribution Evidence:
1. Pancreatic b-cell - Seino S. Journal of Diabetes and Its Complications, 2003: 2-5
Transmembrane prediction: Non-synonymous amino acid changes shown in red, indels (insertions and deletions) in blue, and synonymous changes in green. Exon(s) indicated by black outlines.
Copyright 2009, UCSF Pharmacogenetics of Membrane Transporters. All rights reserved.